A sugar switch for anti-inflammatory antibodies
Article Abstract:
A study suggests that addition of sialic acid to the oligosaccharides on human immunoglobulin G (IgG) molecules enhances their anti-inflammatory activity but might compromise their cytotoxicity, as evidenced in mice by reduced platelet depletion by platelet-specific recombinant monoclonal antibodies (rMAbs). X-ray crystallography reveals multiple noncovalent interactions between the oligosaccharide and the protein, implying that both influence antibody conformation.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2006
User Contributions:
Comment about this article or add new information about this topic:
Post-translational modifications in the context of therapeutic proteins
Article Abstract:
An overview of the range of post-translational modifications (PTMs) associated with natural and recombinant therapeutic proteins is presented and the way such modifications might influence the properties of protein drug candidates is discussed. A better understanding of such structural-functional relationships would facilitate the development of second-generation products displaying a PTM profile engineered to optimize therapeutic usefulness.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2006
User Contributions:
Comment about this article or add new information about this topic:
Biopharmaceutical benchmarks 2006
Article Abstract:
An update on biopharmaceuticals approved during the past three and a half years (from January 2003 to June 2006), examining which types of biopharmaceuticals are launched and for what indications is presented. Overall, some 165 biopharmaceutical products have gained approval, with a market size estimated at some $33 million in 2004 and projected to reach $70 billion by the end of the decade.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2006
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: A passion for collaboration from the get-go: Merk and Co., Inc. and Bioxell show how big pharma and small biotechs can make perfect partners
- Abstracts: Modeling cellular machinery through biological network comparison. Exploiting biological complexity for strain improvement through systems biology
- Abstracts: A liposome-PCR assay for the ultrasensitive detection of biological toxins. Targeted antigen delivery to antigen: presenting cells including dendritic cells by engineered Fas-mediated apoptosis
- Abstracts: DNA patenting: The end of an era? Trust, patents and public perceptions: the governance of controversial biotechnology research
- Abstracts: Learning the language. Good ideas gone bad. Writer's lock